Rekvina Laboratories Appoints Subrata Samanta as CFO

Rekvina Laboratories Limited has announced the appointment of Mr. Subrata Samanta as the Chief Financial Officer (CFO) and Key Managerial Personnel (KMP) of the company. The appointment was approved by the Board of Directors at a meeting held on October 7, 2026, and is effective from the same date. Mr. Samanta brings over 20 years of experience in finance and costing, having previously worked with prominent organizations like Lupin Pharmaceuticals, Glenmark Pharmaceuticals, and Intas Pharmaceuticals. He holds an M.Com degree and is an Associate Cost and Management Accountant (ACMA).